Serum metabolomics and steroid hormone metabolism in patients with polycystic ovary

Study on serum metabolomics and steroid hormone metabolism network in patients with polycystic ovary by LC-MS/MS method - Serum metabolites in polycystic ovary patients based on mass spectrometry

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058593

Enrollment

Unknown

Registered

2022-04-12

Start date

2022-06-01

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome (PCOS)

Interventions

Case group:none

Eligibility

Sex/Gender

Female

Age

18 Years to 44 Years

Inclusion criteria

Inclusion criteria: 1. Chronic ovulatory or anovulatory menstrual cycle interval >=35 days or annual bleeding =12 follicles 2-9 mm in diameter in one or both ovaries, and/or ovarian volume >10 cm.

Exclusion criteria

Exclusion criteria: 1. Pregnant patients; 2. Other diseases that can cause symptoms similar to PCOS, such as hyperthyroidism, Cushing's syndrome, hyperprolactimia, etc.; 3. Take sex hormone drugs within 3 months; 4. Non-menstrual PCOS patients; 5. History of malignancy.

Design outcomes

Primary

Measure	Time frame
Steroid hormones;Serum lipid;Fasting blood glucose;Fasting insulin;Ultrasound B;Metabonomics;	—

Secondary

Measure	Time frame
Cholesterol;Low-density lipoprotein;Follicle-stimulating hormone;Luteinizing hormone;	—

Countries

China

Contacts

Public ContactYang Na

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

shillingyang@163.com+86 18115161056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026